By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Opioids (narcotic analgesics) > Depodur > Depodur Side Effects
Opioids (narcotic analgesics)

DepoDur Side Effects

Note: This document contains side effect information about morphine liposomal. Some dosage forms listed on this page may not apply to the brand name DepoDur.

Applies to morphine liposomal: injectable suspension extended release.

General

The more commonly reported side effects have included nausea, pruritus, pyrexia, vomiting, hypotension, anemia, headache, constipation, decreased oxygen saturation, urinary retention, and dizziness.[Ref]

Respiratory

Very common (10% or more): Decreased oxygen saturation

Common (1% to 10%): Hypoxia, respiratory depression, hypercapnia, dyspnea

Postmarketing reports: Severe respiratory depression, involving apnea or respiratory arrest, and cardiac arrest[Ref]

Prolonged and serious respiratory depression was reported when administration was associated with subarachnoid puncture. In these cases, respiratory depression occurred following apparent recovery from anesthesia (within 12 hours of administration).

Four percent of patients receiving this drug in clinical trials required treatment with narcotic antagonists for respiratory depression; 90% of respiratory depression events were reported within the first 24 hours. Delayed respiratory depression (occurring up to 48 hours postdose) was reported in 2% of patients; 0.6% of patients reported respiratory depression after more than 48 hours. During the postmarketing period, severe respiratory depression involving apnea or respiratory arrest have been reported following administration of labeled doses.[Ref]

Nervous system

Postmarketing reports: Central nervous system depression, including obtunded feeling, non-arousable condition, unresponsiveness, confusion, and lethargy[Ref]

CNS depression, including obtunded feeling, non-arousable condition, unresponsiveness, confusion, and lethargy, has been reported. In most cases, there was concomitant administration of different narcotics or hypnotic/sedative medications in the post-operative period.[Ref]

Cardiovascular

Very common (10% or more): Hypotension

Common (1% to 10%): Tachycardia, hypertension, bradycardia[Ref]

Gastrointestinal

Very common (10% or more): Vomiting, constipation, nausea

Common (1% to 10%): Flatulence, paralytic ileus, dyspepsia, abdominal distension[Ref]

Dermatologic

Very common (10% or more): Pruritus

Common (1% to 10%): Hypoesthesia, increased sweating[Ref]

Musculoskeletal

Common (1% to 10%): Rigors[Ref]

Metabolic

Common (1% to 10%): Hypokalemia

Psychiatric

Common (1% to 10%): Anxiety

Hematologic

Very common (10% or more): Anemia

Common (1% to 10%): Decreased hematocrit[Ref]

Genitourinary

Very common (10% or more): Urinary retention

Common (1% to 10%): Bladder spasm, oliguria[Ref]

Share this Article
Latest News
Medical News

Mental health: Low-calorie diets may increase depression

Jun 07, 2025
Psilocybin for IBS: Could altering the mind help alter the gut?
Colon cancer: Adding immunotherapy may halve death, recurrence rate
Colon cancer: Exercise as important as drugs in preventing recurrence
Alzheimer's: Common insomnia treatment may prevent brain damage
Cholesterol: Daily cup of beans may lower levels, improve heart health
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by